Rare cases of bone fragility or disorders (case reports).
La Hulpe 11-12/03/2016
Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).
Rome 01/02/2014
Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.
Brussel 01/01/2014
Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.
Brussel 01/01/2014
Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.
Oostende + San Diego 01/01/2013
Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.
La Hulpe 01/01/2012
Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.